Background/Aims: Youth with type 2 diabetes (T2D) have poor compliance with medical care. This study aimed to determine which demographic and clinical factors differ between youth with T2D who receive care in a pediatric diabetes center versus youth lost to follow-up for >18 months. Methods: Data were analyzed from 496 subjects in the Pediatric Diabetes Consortium registry. Enrollment variables were selected a priori and analyzed with univariable and multivariable logistic regression models. Results: After a median of 1.3 years from enrollment, 55% of patients were lost to follow-up. The final model included age, race/ethnicity, parent education, and estimated distance to study site. The odds ratio (99% confidence interval) of loss to follow-up was 2.87 (1.34, 6.16) for those aged 15 to <18 years versus those aged 10 to <13 years and 6.57 (2.67, 16.15) for those aged ≥18 years versus those aged 10 to <13 years. Among patients living more than 50 miles from the clinic, the odds ratio of loss to follow-up was 3.11 (1.14, 8.49) versus those living within 5 miles of the site. Conclusion: Older adolescents with T2D are more likely to be lost to follow-up, but other socioeconomic factors were not significant predictors of clinic follow-up.
Introduction
Type 2 diabetes (T2D) is a growing pediatric health concern, accounting for 22% of new diabetes cases among youth in the United States [1] . It is estimated that the number of youth with T2D will increase 4-fold by 2050 [2] . In addition, youth diagnosed with T2D have increased morbidity and mortality compared with youth diagnosed with type 1 diabetes (T1D) [3] or those diagnosed with T2D at >30 years of age [4] . Youth diagnosed with T2D are at a particularly high risk of early nephropathy. Fifteen years after diagnosis, 26% of youth with T2D have experienced at least 1 major complication (dialysis, blindness, or amputations) [5] . The rate of major complications increases to 47.9% twenty years after diagnosis [5] . In T2D, mortality is inversely correlated with age at diagnosis, and patients diagnosed with T2D at <30 years of age have a 36% greater mortality risk than those diagnosed at 30-39 years of age [4] .
Despite differences in pathophysiology, treatment, and prognosis, youth with T2D are typically offered clinical care and diabetes education based on programs developed for T1D [6] . Pediatric endocrinologists report that compliance is worse in the T2D population and 29% reported a more negative attitude toward patients with T2D compared with patients with T1D [6] . Poor compliance with medical care and inconsistent visit attendance may contribute to the increased morbidity and mortality seen in youth with T2D.
In order to improve the clinical care of patients with T2D, we must first identify potentially modifiable barriers to care, which may differ from the T1D population. Potential barriers include socioeconomic challenges and cultural or language barriers [6] . In this paper, we utilized the Pediatric Diabetes Consortium (PDC) T2D Registry to compare the demographic and clinical characteristics of youth with continued follow-up at a pediatric diabetes center versus youth who failed to return for follow-up within 18 months.
Methods

Patients
The PDC began enrollment in February 2012. Data were analyzed from the 496 subjects from 7 US diabetes centers who had been enrolled in the registry for a minimum of 18 months. Registry enrollment criteria included age <21 years and a diagnosis of T2D according to the American Diabetes Association criteria [7] . All patients had a physician diagnosis of T2D based on weight at diagnosis (body mass index [BMI] >85th percentile for age and gender prior to diabetes-associated weight loss), metabolic syndrome phenotype, and negative diabetes autoantibodies, if available. The research protocol was approved by each institution's IRB, and appropriate consent and assent were obtained prior to enrollment.
Data Collection
Data were collected from the medical record and participant/ parent interview at the time of enrollment and updated yearly. Participant-reported race/ethnicity and parent education history were obtained. Age, gender, health insurance type, diabetes duration, HbA 1c , self-monitoring blood glucose tests per day, and medication regimen were recorded from patient report and the medical record. The distance between a patient's home and the clinic site was approximated using latitude and longitude of the center of their respective zip codes. Participants were classified as lost to follow-up if they had not had a clinic follow-up visit for >18 months.
Statistical Analysis
Enrollment variables (study site, age, gender, race/ethnicity, parent education, diabetes duration, HbA 1c , health insurance, blood glucose self-monitoring, distance from site, and type of diabetes treatment) were chosen a priori by the investigators based on potential impact on clinic follow-up or as markers of compliance with the clinical care plan. Continuous data are presented as median (interquartile range, IQR). A univariable logistic regression model was used to assess the association of each risk factor with participant status (active or lost to follow-up). Then, a multivariable logistic regression model was constructed using stepwise selection methods. Only factors with a p value <0.10 during the stepwise selection procedure were included in the multivariable model to adjust for possible confounding. Due to multiple comparisons, only factors with p values <0.01 were considered statistically significant. For continuous variables, linearity was tested, and if a nonlinear trend was detected, either higher-order polynomials were added or the variable was discretized. All reported p values are two-sided. Analysis was conducted using SAS version 9.4 (SAS institute, Cary, NC, USA).
Results
The 496 participants had a median (IQR) age of 16.0 years (14.1-17.8) and the majority were female (65%). Participants self-identified as Hispanic (54%), African American (30%), White (9%), and other (6%). Only 30% of parents had an education beyond high school, and 62% of the participants had Children's Health Plan or other government health insurance. At enrollment, 85% were classified as obese (BMI ≥95th percentile for age and gender). The median (IQR) HbA 1c was 7.3% (6.0-9.4) (56 mmol/mol [42-79]), and participants tested their blood glucose 2 times per day (1-3). The median (IQR) diabetes duration was 2.1 years (0.8-4.5) at enrollment. After a median (IQR) of 1.3 years (0.5-2.3) of follow-up (from enrollment to the last visit date), 55% of patients had been lost to follow-up. The median (IQR) follow-up time was 2.3 years (1.9-2.8) among active participants and 0.7 years (0-1.1) among those lost to follow-up. The baseline characteristics of the active participants and the lost to follow-up group are detailed in Table 1 .
The univariable and multivariable analyses are presented in Table 2 . The only factor that met our criteria for significance in the final multivariable model was age. 47 (9) 24 (9) 23 (10) 004 90 (18) 46 (17) 44 (20) 005 25 (5) 12 (4) 13 (6) 006 67 (14) 36 (13) 31 (14) 008 81 (16) 47 (17) 34 ( for the adult participants (≥18 years old) versus those aged 10 to <13 years. Since older patients may be more likely to leave a pediatric practice and seek care from a local adult provider, we also performed a post hoc analysis excluding patients who were ≥18 years old at enrollment and found no change in the results. Among patients living more than 50 miles away from the clinic, the odds ratio of loss to follow-up was 3.11 (1.14, 8.49) versus those living within 5 miles of the site. BMI and family status were not associated with loss to follow-up rate (data not shown).
Discussion
In this large, multi-center cohort of youth with T2D, 55% of patients were lost to follow-up after a median of 1.3 years (from enrollment to the last visit date). This high percentage highlights the challenges of caring for this population. We found that older adolescents are more likely to be lost to follow-up than younger children. Other socioeconomic factors were not significant predictors of clinic follow-up. The rate of loss to follow-up in the PDC registry T2D cohort was much higher compared with the T1D cohort, with a loss to follow-up rate of only 18% after a median of 2.9 years (unpubl. data).
Much of our knowledge about the demographic characteristics of T2D comes from the Treatment Options in Type 2 Diabetes in Youth trial (TODAY) and the SEARCH for Diabetes study [8, 9] . While T1D accounts for >95% of diabetes diagnoses in White youth, 25% of diabetes cases in Hispanic, Black, and Asian/Pacific Islander patients are T2D [9] . Patients with T2D are disproportionately from economically disadvantaged backgrounds as shown in this study and the TODAY trial. More than 40% of TODAY study participants reported a household income of <$25,000 per year, and the majority of parents reported a high school education or less [8] . The TODAY study was carefully designed to help minimize barriers to follow-up and medication compliance, utilizing a greater number of resources than typical clinical practice. In this resource-intense setting, more than 90% of randomized patients completed the multi-year study (average followup, 3.8 years) [10] . In contrast, we report that more than 50% of patients are lost to follow-up in a clinical care setting. The PDC T2D cohort described in this study is 85% Black or Hispanic, and 70% of parents have a high school education or less. In comparison, a contemporaneous PDC T1D cohort, drawn from the same pediatric diabetes centers, has almost opposite demographics -majority White with a relatively high median income and parental education [11] . Despite the vast socioeconomic differences between T1D and T2D patients, clinical care for youth with T2D is typically provided in a T1D clinic setting. This care is provided by physicians and staff with more experience with T1D than with T2D. Less than a quarter of pediatric diabetes clinics report using diabetes education programs designed specifically for T2D, and most clinics use the same staff to care for both T1D and T2D [6] . T1D education programs may fail to recognize the (4) 3 (1) Data are presented as n (%), unless otherwise indicated. a Number of participants with missing or "unknown" data (lost to followup/active): race/ethnicity (1/3), parent education (20/19), BMI (26/11), HbA 1c (30/16).
b Site 007 dropped out of the registry and patient follow-up data were unavailable.
c Self-reported values. cultural diversity present in T2D clinic populations. In order to develop T2D-specific diabetes care models, we must address cultural differences, language barriers, and possible limitations of both reading level and numeracy skills in patients with T2D and their parents [12] .
As clinicians have begun to recognize the unique challenges of T2D, several potential barriers to care have been hypothesized. The majority of pediatric diabetes providers have identified culture/language as a barrier to successful treatment of T2D [6] . Although we did not find that a particular race or ethnicity influenced clinic followup, addressing cultural barriers may improve T2D care. Other provider concerns have included the unhealthy lifestyle of family members and the lack of immediate consequences from uncontrolled T2D [6] for poor follow-up seen in T2D youth.
In this study, the main predictor of loss to follow-up was increasing patient age. Older patients may be more likely to receive care from a local adult provider, but a post hoc analysis excluding patients aged ≥18 years did not alter our results. Adolescents also report a desire to fit in with their peers which interferes with both healthy diet choices and diabetes management [13] . However, increasing age has not been associated with loss to followup in pediatric weight management clinics [14, 15] . Further research is needed to better understand why older adolescents are less likely to continue to receive care at pediatric diabetes centers.
Financial stress is reported as a barrier to care, impeding access to medications, clinic visits, and the purchase of healthy foods [13] . We were unable to include patientreported income as a variable due to high rates of missing data. Insurance type was used as a surrogate for household income but was not associated with clinic loss to follow-up. We were unable to use zip code as a surrogate for income as there was poor correlation between our available income data and zip code-based data from the 2014 Five-Year American Community Survey. It does appear that distance from the clinic site may influence clinic follow-up. Longer travel distances pose a challenge to families without private transportation, and longer travel time means more hours of missed work. Travel distance has also been associated with unsuccessful transition from pediatric to adult sickle cell disease centers [16] . In adults, the majority of studies have shown worse health outcomes, including follow-up non-attendance, for patients living further away from healthcare facilities [17] .
Novel treatment paradigms utilizing satellite clinics, telemedicine, or home health services could reduce patient burden and improve access to care. A recent metaanalysis of 55 randomized controlled trials found that telemedicine provided a larger reduction in HbA 1c than traditional treatment programs and was particularly effective for T2D versus T1D [18] . Despite the effectiveness in adult populations, none of the 55 studies included pediatric patients with T2D. Telemedicine interventions may combine online modules, videoconferencing, or motivational text messages or prompts with less frequent clinic or home health visits. Telemedicine has been effective in minority, urban, and rural populations [19] [20] [21] .
Our study is limited by the lack of data related to why patients stopped seeking care in the pediatric diabetes clinic. T2D youth may be receiving medical care from primary care providers. It is possible that primary care providers are more comfortable with the management of T2D and more likely to assume care of adolescents with T2D versus T1D. The main advantage of our cohort is that it reflects routine clinical care at 7 pediatric diabetes centers, though the efforts of study staff to contact patients may mean that we have underestimated the loss to follow-up rate. While clinicians have long suspected poor clinic follow-up in patients with T2D, this study is the first to quantify the loss to follow-up rate. We believe that T2D care requires a new clinic model that is specifically designed for these adolescent patients and addresses the unique socioeconomic, cultural, and language barriers of this population. Next steps include evaluating in pediatric clinics the effectiveness of available culturally sensitive T2D diabetes education models that have been validated in adult populations [12] . We also recommend investigating telemedicine, as distance from the clinic was an identifiable barrier to care for these adolescent patients.
